These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29720027)

  • 1. Efficacy of Testosterone Treatment in Hemodialysis Patients as Assessed by Aging Males' Symptoms Scores: A Pilot Study.
    Inoue Y; Nakamura K; Kuwahara Y; Lu Y; Masuda N; Horie S; Okada H; Ide H
    Am J Mens Health; 2018 Sep; 12(5):1541-1547. PubMed ID: 29720027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale.
    Ho CC; Tong SF; Low WY; Ng CJ; Khoo EM; Lee VK; Zainuddin ZM; Tan HM
    BJU Int; 2012 Jul; 110(2):260-5. PubMed ID: 22093057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study.
    Legros JJ; Meuleman EJ; Elbers JM; Geurts TB; Kaspers MJ; Bouloux PM;
    Eur J Endocrinol; 2009 May; 160(5):821-31. PubMed ID: 19211706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
    Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
    Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
    Amano T
    Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel testosterone gel improves serum testosterone concentrations and aging males' symptoms in patients with late-onset hypogonadism: an active control equivalence, randomized, double-blind, crossover study.
    Shirai M; Tsujimura A; Mizushima K; Tsuru T; Kurosawa M; Kure A; Uesaka Y; Nozaki T; Kobayashi K; Horie S
    Endocr J; 2023 Apr; 70(4):403-409. PubMed ID: 36529505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial.
    Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M
    Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of serum testosterone levels after application of testosterone ointment (glowmin) and its clinical efficacy in late-onset hypogonadism patients.
    Amano T; Imao T; Takemae K; Iwamoto T; Yamakawa K; Baba K; Nakanome M; Sugimori H; Tanaka T; Yoshida K; Katabami T; Tanaka M
    J Sex Med; 2008 Jul; 5(7):1727-36. PubMed ID: 18093097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
    Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
    J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
    Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
    Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
    Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
    Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity].
    Amano T; Imao T; Takemae K; Iwamoto T; Baba K; Yamakawa K; Nakazawa R; Yoshida K; Sugimori H; Tanaka T; Katabami T; Tanaka M
    Hinyokika Kiyo; 2007 Jan; 53(1):25-9; discussion 29. PubMed ID: 17310765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism?
    Tsujimura A; Takada S; Matsuoka Y; Hirai T; Takao T; Miyagawa Y; Nonomura N; Okuyama A
    Int J Urol; 2008 Jul; 15(7):625-9. PubMed ID: 18479356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients.
    Strollo F; Strollo G; Morè M; Magni P; Macchi C; Masini MA; Carucci I; Celotti F; Ruscica M; Gentile S
    Aging Male; 2013 Jun; 16(2):33-7. PubMed ID: 23517433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism.
    Okada K; Yamaguchi K; Chiba K; Miyake H; Fujisawa M
    Aging Male; 2014 Jun; 17(2):72-5. PubMed ID: 24533913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials.
    Nian Y; Ding M; Hu S; He H; Cheng S; Yi L; Li Y; Wang Y
    Andrologia; 2017 May; 49(4):. PubMed ID: 27389320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P
    J Sex Med; 2013 Jun; 10(6):1612-27. PubMed ID: 23551886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of short-acting testosterone ointment (Glowmin) for late-onset hypogonadism in accordance with testosterone circadian rhythm.
    Amano T; Iwamoto T; Sato Y; Imao T; Earle C
    Aging Male; 2018 Sep; 21(3):170-175. PubMed ID: 29734846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of late-onset hypogonadism among middle-aged and elderly males in China: results from a national survey.
    Liu YJ; Shen XB; Yu N; Shang XJ; Gu YQ; Zuo LD; Xiong CL; Ye Z; Zhou YZ
    Asian J Androl; 2021; 23(2):170-177. PubMed ID: 33154202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of testosterone treatment on bone mineral density in men with testosterone deficiency syndrome.
    Rodriguez-Tolrà J; Torremadé J; di Gregorio S; Del Rio L; Franco E
    Andrology; 2013 Jul; 1(4):570-5. PubMed ID: 23686863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.